Capsule Summary Slidesets

Share

Program Content

Activities

  • Olaparib + Abiraterone in mCRPC
    Phase II Trial: Olaparib + Abiraterone vs Placebo + Abiraterone for Metastatic CRPC Following Chemotherapy
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 03, 2018

    Expires: June 02, 2019

  • PROs in IMmotion151
    IMmotion151: Patient-Reported Outcomes With First-line Atezolizumab + Bevacizumab vs Sunitinib in Treatment-Naive Metastatic RCC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 05, 2018

    Expires: June 04, 2019

  • KEYNOTE-427
    KEYNOTE-427 (Cohort A): Phase II Study of Pembrolizumab Monotherapy for First-line Treatment of Patients With Advanced Clear-Cell Renal Cell Carcinoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 06, 2018

    Expires: June 05, 2019

  • Lenvatinib + Pembro in mRCC
    Phase Ib/II Study of Lenvatinib + Pembrolizumab for Patients With Metastatic Renal Cell Carcinoma: Updated Results
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 07, 2018

    Expires: June 06, 2019

  • ABACUS: Neoadjuvant Atezolizumab
    Phase II ABACUS: Neoadjuvant Atezolizumab in Muscle-Invasive Bladder Cancer (Interim Analysis)
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 07, 2018

    Expires: June 06, 2019

  • EV-101: Enfortumab Vedotin in mUC
    EV-101: Updated Results From Phase I Study of Enfortumab Vedotin in Patients With Metastatic Urothelial Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 08, 2018

    Expires: June 07, 2019

  • KEYNOTE-199: Pembrolizumab in mCRPC
    KEYNOTE-199: Phase II Study of Pembrolizumab in Post-Docetaxel Metastatic Castration-Resistant Prostate Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 08, 2018

    Expires: June 07, 2019

  • Erdafitinib in <i>FGFR</i>+ UC
    BLC2001: Phase II Trial of FGFR Inhibitor Erdafitinib in Patients With FGFR-Altered Metastatic or Unresectable Urothelial Carcinoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 12, 2018

    Expires: June 11, 2019

  • PURE-01: Neoadjuvant Pembrolizumab
    Interim Analysis of Phase II PURE-01 Trial: Neoadjuvant Pembrolizumab in Patients With Muscle-Invasive Urothelial Bladder Carcinoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 12, 2018

    Expires: June 11, 2019

  • CARMENA: Sunitinib ± Prior Nephrectomy in mRCC
    CARMENA: Cytoreductive Nephrectomy Followed by Sunitinib vs Sunitinib Alone in Patients With Metastatic Renal Cell Carcinoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

Provided by

ProCE Banner

Supporters

Amgen, Inc.

Astellas Text

AstraZeneca

Celgene

Eisai

Genentech TEXT Only

Janssen

Merck Oncology

Seagen